Celvapan
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Made by
- Nanotherapeutics Bohumil, s.r.o.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Prophylaxis of influenza caused by A(H1N1)v 2009 virus. Celvapan should be used in accordance with official guidance.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | Nanotherapeutics Bohumil, s.r.o. |
|---|---|
| Active substance | Influenza vaccine (H1N1)v (whole virion, Vero cell derived, inactivated) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07BB01 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2009-03-04 |
| Last updated by the regulator | 2016-12-21 |
| EMA product number | EMEA/H/C/000982 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).